Smith HL - Search Results

1

DNA damage checkpoint kinases in cancer.

Smith HL, Southgate H, Tweddle DA, Curtin NJ. Smith HL, et al. Expert Rev Mol Med. 2020 Jun 8;22:e2. doi: 10.1017/erm.2020.3. Expert Rev Mol Med. 2020. PMID: 32508294 Review.

2

Exploring the Synergy between PARP and CHK1 Inhibition in Matched BRCA2 Mutant and Corrected Cells.

Smith HL, Prendergast L, Curtin NJ. Smith HL, et al. Cancers (Basel). 2020 Apr 4;12(4):878. doi: 10.3390/cancers12040878. Cancers (Basel). 2020. PMID: 32260355 Free PMC article.

3

Differences in Durability of PARP Inhibition by Clinically Approved PARP Inhibitors: Implications for Combinations and Scheduling.

Smith HL, Willmore E, Mukhopadhyay A, Drew Y, Curtin NJ. Smith HL, et al. Cancers (Basel). 2022 Nov 12;14(22):5559. doi: 10.3390/cancers14225559. Cancers (Basel). 2022. PMID: 36428653 Free PMC article.

4

MicroRNA levels quantified in whole blood varies from PBMCs.

Atarod S, Smith H, Dickinson A, Wang XN. Atarod S, et al. F1000Res. 2014 Aug 5;3:183. doi: 10.12688/f1000research.4884.4. eCollection 2014. F1000Res. 2014. PMID: 26500764 Free PMC article.

5

Impact of education and clinic site champion on extragenital testing for sexually transmitted infections.

Cunningham VC, Hurdelbrink J, Smith HL, Sittig KR, Veach LA. Cunningham VC, et al. Among authors: smith hl. Int J STD AIDS. 2024 May 16:9564624241254875. doi: 10.1177/09564624241254875. Online ahead of print. Int J STD AIDS. 2024. PMID: 38756016

6

Regulatory Considerations in the Approval of Rezafungin (REZZAYO) for the Treatment of Candidemia and Invasive Candidiasis in Adults.

Smith HL, Bensman TJ, Mishra S, Li X, Dixon CA, Sheikh J, McMaster OG, Joshi A, Rubin DB, Goodwin A, Miller TJ, Danielsen ZY, Syed I, Shukla SJ, Iarikov D, Kim PW, Farley JJ. Smith HL, et al. J Infect Dis. 2024 Mar 19:jiae146. doi: 10.1093/infdis/jiae146. Online ahead of print. J Infect Dis. 2024. PMID: 38502709

7

Impact of Simulation Manikins to Train Pharmacy Students in Nasal, Throat, and Oral Fluid Swab Collection.

Bryant GA, Bottenberg MM, Smith HL, Challoner M, Fisher T. Bryant GA, et al. Among authors: smith hl. Innov Pharm. 2023 Nov 20;14(4):10.24926/iip.v14i4.5046. doi: 10.24926/iip.v14i4.5046. eCollection 2023. Innov Pharm. 2023. PMID: 38495350 Free PMC article.

8

Excitotoxicity and ALS: New therapy targets an old mechanism.

Smith HL, Chaytow H, Gillingwater TH. Smith HL, et al. Cell Rep Med. 2024 Feb 20;5(2):101423. doi: 10.1016/j.xcrm.2024.101423. Cell Rep Med. 2024. PMID: 38382464 Free PMC article.

9

Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.

Mendoza RP, Wang P, Smith HL, Fitzpatrick CA, Haridas R, Wanjari P, Briese R, Shahid A, McCluggage WG, Bennett JA. Mendoza RP, et al. Among authors: smith hl. Am J Surg Pathol. 2023 Dec 1;47(12):1398-1408. doi: 10.1097/PAS.0000000000002124. Epub 2023 Oct 5. Am J Surg Pathol. 2023. PMID: 37796179

10

Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.

Albert-Gasco H, Smith HL, Alvarez-Castelao B, Swinden D, Halliday M, Janaki-Raman S, Butcher AJ, Mallucci GR. Albert-Gasco H, et al. Among authors: smith hl. Brain. 2024 Feb 1;147(2):649-664. doi: 10.1093/brain/awad313. Brain. 2024. PMID: 37703312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

497 results

Search Page